KARYOPHARM THERAP.DL-0001 earnings per share and revenue

25K earnings per share for the last quarter are -0.30 EUR whereas the estimation was -0.31 EUR which accounts for 4.15% surprise. Företagets omsättning för samma period uppgår till 30.70 M EUR trots den uppskattade siffran 31.96 M EUR. Estimated earnings per share for the next quarter are -0.29 EUR, and revenue is expected to reach 33.32 M EUR. Also watch annual changes over time to get a bigger picture of 25K earnings per share and revenue dynamics.